Comparison of neopterin levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease

Southern Medical Journal

Volumn 101, Issue 5, 2008, Pages 476-479

  Şahin, Mehmet ^a   Varol, Ercan ^a   Ozaydin, Mehmet ^a   Altinbas, Ahmet ^a   Aydin, Osman ^a   Aslan, Suleyman M ^a   Dogan, Abdullah ^a   Kaya, Selçuk ^a  

^a NONE

Author keywords

Coronary artery disease; Coronary artery ectasia; Neopterin

Indexed keywords

NEOPTERIN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DISEASE; ARTERY OCCLUSION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ANOMALY; CORONARY ARTERY ECTASIA; CORONARY ARTERY OBSTRUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADULT; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY DISEASE; CORONARY VESSELS; DILATATION, PATHOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPTERIN; REGRESSION ANALYSIS;

EID: 43149121315     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31815d22f4     Document Type: Article

References (23)

1. Swaye PS, Fisher LD, Litwin P, et al. Aneurysmal coronary artery disease. Circulation 1983;67:134-138.
2. Kosar F, Acikgoz N, Sahin I, et al. Effect of ectasia size or the ectasia ratio on the thrombosis in myocardial infarction frame count in patients with isolated coronary artery ectasia. Heart Vessels 2005;20:199-202.
3. Swanton RH, Lea Thomas M, Coltarte DJ, et al. Coronary artery ectasia, a variant of occlusive coronary arteriosclerosis. Br Heart J 1987;40:393-400.
4. Markis JE, Joffe CD, Cohn PF, et al. Clinical significance of coronary artery ectasia. Am J Cardiol 1976;37:217-222.
5. Koch AE, Haines GK, Rizzo RJ, et al. Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990;137:1199-1213.
6. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160:310-316.
7. Tatzber F, Rabl H, Koriska K, et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991;89:203-208.
8. Weiss G, Willeit J, Kiechl S, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994;106:263-271.
9. Gupta S, Fredericks S, Schwartzman RA, et al. Serum neopterin in acute coronary syndromes. Lancet 1997;349:1252-1253.
10. Scumacher M, Halwachs G, Tatzber F, et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997;30:703-707.
11. Garcia-Moll X, Coccolo F, Cole D, et al. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000;35:956-962.
12. Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004;90:847-852.
13. Avanzos P, Arroyo-Espliguero R, Quiles J, et al. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005;26:457-463.
14. Zouridakis E, Avanvas P, Arroyo-Espliguero R, et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004;110:1747-1753.
15. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
16. Tokgozoglu L, Ergene O, Kýnay O, et al. Plasma interleukin-6 levels are increased in coronary artery actasia. Acta Cardiol 2004;59:515-519.
17. Turhan H, Erbay AR, Yasar AS, et al. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery actasia. Coron Artery Dis 2005;16:45-50.
18. Turhan H, Erbay AR, Yasar AS, et al. Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease. Am J Cardiol 2004;94:1303-1306.
19. Iizuka T, Minatogawa Y, Suzuki H, et al. Urinary neopterin as a predictive marker of coronary artery abnormalities in Kawasaki syndrome. Clin Chem 1993;39:600-604.
20. Diamondstone LS, Tollerud DJ, Fuchs D, et al. Factors influencing serum neopterin and β2-microglobulin levels in healthy diverse population. J Clin Immunol 1994;14:368-374.
21. Schennach H, Murr C, Gächter E, et al. Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem 2002;48:643- 645.
22. Walter RB, Fuchs D, Weiss G, et al. HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease. Clin Chem Lab Med 2003;41:1314-1319.
23. Yetkin E, Waltenberger J. Novel insight into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis? Clin Res Cardiol 2007;96:331-339.